The purpose of the present study is to evaluate the safety and efficacy of “low‐dose” systemic thrombolytic therapy (TT) for treatment of patients with intermediate‐high risk submassive pulmonary embolism (PE). Click to show full abstract
The purpose of the present study is to evaluate the safety and efficacy of “low‐dose” systemic thrombolytic therapy (TT) for treatment of patients with intermediate‐high risk submassive pulmonary embolism (PE).
               
Click one of the above tabs to view related content.